Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, identity-by-descent and model-based classification
Understanding the genetic relatedness of Plasmodium vivax recurrences is essential for distinguishing between relapse, reinfection, and recrudescence—a distinction critical for evaluating treatment efficacy and transmission dynamics. We developed P. vivax AmpSeq (PvAmpSeq), an amplicon sequencing assay targeting 11 single-nucleotide polymorphism (SNP)-rich genomic regions. PvAmpSeq was applied to field isolates from a clinical trial in the Solomon Islands and a longitudinal cohort in Peru, and statistical models were applied for the genetic classification of recurrences. In the Solomon Islands trial, where participants received antimalarials at baseline, half of the recurrent infections showed >50% identity-by-descent relatedness to baseline parasites, allowing statistical classification as probable relapses and recrudescences, although with wide uncertainty. In the Peruvian cohort, 68% of the recurrences exhibited <25% relatedness. PvAmpSeq provides high-resolution genotyping to characterize P. vivax recurrences, offering insights into transmission and treatment outcomes. We also discuss the nuances and limitations of available statistical methods for the classification of P. vivax genotyping data.
Citation
@article{rosado2026,
author = {Rosado, Jason and Han, Jiru and Obadia, Thomas and Munro,
Jacob and Traore, Zeinabou and Schoffer, Kael and Brewster, Jessica
and Bourke, Caitlin and M. Vinetz, Joseph and R. Taylor, Aimee and
White, Michael and Bahlo, Melanie and Gamboa, Dionicia and Mueller,
Ivo and Ruybal-Pesántez, Shazia},
title = {Understanding {Plasmodium} Vivax Recurrent Infections Using
an Amplicon Deep Sequencing Assay, Identity-by-Descent and
Model-Based Classification},
journal = {iScience},
volume = {29},
number = {5},
date = {2026-04-18},
url = {https://doi.org/10.1016/j.isci.2026.115799},
doi = {10.1016/j.isci.2026.115799},
langid = {en},
abstract = {Understanding the genetic relatedness of Plasmodium vivax
recurrences is essential for distinguishing between relapse,
reinfection, and recrudescence—a distinction critical for evaluating
treatment efficacy and transmission dynamics. We developed P. vivax
AmpSeq (PvAmpSeq), an amplicon sequencing assay targeting 11
single-nucleotide polymorphism (SNP)-rich genomic regions. PvAmpSeq
was applied to field isolates from a clinical trial in the Solomon
Islands and a longitudinal cohort in Peru, and statistical models
were applied for the genetic classification of recurrences. In the
Solomon Islands trial, where participants received antimalarials at
baseline, half of the recurrent infections showed \textgreater50\%
identity-by-descent relatedness to baseline parasites, allowing
statistical classification as probable relapses and recrudescences,
although with wide uncertainty. In the Peruvian cohort, 68\% of the
recurrences exhibited \textless25\% relatedness. PvAmpSeq provides
high-resolution genotyping to characterize P. vivax recurrences,
offering insights into transmission and treatment outcomes. We also
discuss the nuances and limitations of available statistical methods
for the classification of P. vivax genotyping data.}
}